Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease
出版年份 2020 全文链接
标题
Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease
作者
关键词
-
出版物
CIRCULATION
Volume 141, Issue 17, Pages 1384-1392
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2020-03-19
DOI
10.1161/circulationaha.119.044059
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle
- (2018) Prabir Roy-Chaudhury et al. KIDNEY INTERNATIONAL
- Apixaban Pharmacokinetics at Steady State in Hemodialysis Patients
- (2017) Thomas A. Mavrakanas et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF
- (2016) Kevin E. Chan et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine
- (2016) John H. Alexander et al. JAMA Cardiology
- Risk of Stroke in Patients with ESRD
- (2015) P. Masson et al. Clinical Journal of the American Society of Nephrology
- Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis
- (2015) Xiaoli Wang et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Changes in Renal Function in Patients With Atrial Fibrillation
- (2015) Michael Böhm et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
- (2014) Craig T. January et al. CIRCULATION
- Risk of Stroke in Long-term Dialysis Patients Compared With the General Population
- (2013) Hsi-Hao Wang et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Statin Use and Calcific Uremic Arteriolopathy: A Matched Case-Control Study
- (2013) Sagar U. Nigwekar et al. AMERICAN JOURNAL OF NEPHROLOGY
- Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis
- (2013) T. van der Hulle et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chronic kidney disease and prevalent atrial fibrillation: The Chronic Renal Insufficiency Cohort (CRIC)
- (2010) Elsayed Z. Soliman et al. AMERICAN HEART JOURNAL
- Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale
- (2010) Renato D. Lopes et al. AMERICAN HEART JOURNAL
- Warfarin in haemodialysis patients with atrial fibrillation: what benefit?
- (2010) F. Yang et al. EUROPACE
- Close bidirectional relationship between chronic kidney disease and atrial fibrillation: The Niigata preventive medicine study
- (2009) Hiroshi Watanabe et al. AMERICAN HEART JOURNAL
- Prevalence of Atrial Fibrillation and Its Predictors in Nondialysis Patients with Chronic Kidney Disease
- (2009) W. Ananthapanyasut et al. Clinical Journal of the American Society of Nephrology
- Anticoagulant and Antiplatelet Usage Associates with Mortality among Hemodialysis Patients
- (2009) K. E. Chan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More